ePrints

Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide

Lookup NU author(s): Professor Ruth Plummer, Professor Alan Boddy, Professor Nicola CurtinORCiD, Professor Herbie Newell, Lynsey Robson, Professor Alan Calvert

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Plummer ER, Middleton M, Wilson R, Evans J, Jones C, Olson A, Boddy AV, Curtin NJ, Kaufman R, Harris A, Johnston P, Newell DR, Robson L, Dewji R, Calvert AH

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics

Year of Conference: 2005

Pages: 9099S-9099S

ISSN: 1078-0432

Publisher: Clinical Cancer Research: American Association for Cancer Research

Notes:

Library holdings: Search Newcastle University Library for this item

ISBN:

Share